Study guide

11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology

Key Takeaways Explain This Topic AI

The anatomical separation of temporal retinal ganglion cell axons at the horizontal raphe causes all glaucomatous nerve fiber bundle defects to strictly respect the nasal horizontal meridian.

The classic progression of glaucomatous field loss initiates as an isolated nasal step or paracentral scotoma, coalesces into a Seidel and full arcuate (Bjerrum) scotoma, and culminates in a double arcuate ring leaving a central island and temporal crescent.

Branch Retinal Artery Occlusions (BRAO) create sudden, dense, absolute altitudinal field deficits that respect the horizontal raphe, but correlate with acute retinal whitening and arteriolar boxcarring.

Plaquenil (hydroxychloroquine) toxicity screening mandates 10-2 testing with white stimuli for non-Asian patients (parafoveal 2–6° ring scotoma) and 24-2 or 30-2 testing for Asian patients due to a wider pericentral pattern of toxicity.

Toxoplasmosis lesions adjacent to the optic nerve head can sever overlying nerve fiber bundles, generating an arcuate-shaped visual field scotoma termed Jensen's choroiditis.

Last updated: September 2026

Visual Field Defect Patterns: Glaucomatous vs. Retinal Pathology

Core Clinical Mandate: Accurate interpretation of visual field loss requires an intimate understanding of retinal nerve fiber layer (RNFL) topography. Retinal ganglion cell axons follow strict anatomical trajectories that dictate the exact geometric contours of visual field defects. The COMT must distinguish classic glaucomatous nerve fiber bundle patterns from mimicking retinal conditions, such as branch retinal vascular occlusions, chorioretinal scars, rhegmatogenous retinal detachments, hereditary tapetoretinal dystrophies, and antimalarial medication toxicities.

Neuroanatomical Architecture of the Retinal Nerve Fiber Layer

The human retina contains approximately 1.0 to 1.2 million retinal ganglion cells (RGCs). The unmyelinated axons of these cells traverse the inner retina in three highly segregated structural divisions before converging at the optic nerve head: Retinal Nerve Fiber Layer (RNFL) Trajectories:

  • ├── 1. Papillomacular Bundle (Central 1/3 of disc; fine, densely packed central foveal axons)
  • ├── 2. Nasal Radial Fibers (Direct, straight radial entry from nasal retina)
  • └── 3. Arcuate Fibers (Superior & Inferior)
  • ├── Arise from temporal retina
  • ├── Arch widely around the papillomacular bundle
  • └── Segregated strictly by the TEMPORAL HORIZONTAL RAPHE
  • 1. The Temporal Horizontal Raphe

Anatomical Demarcation: In the temporal retina, axons originating superior to the horizontal midline never cross into the inferior retina, and inferior axons never cross into the superior retina. They are separated by a sharp physiological boundary known as the horizontal raphe .

Perimetric Translation: Because optical projection inverts images both vertically and horizontally, the temporal retinal horizontal raphe projects to the nasal visual field horizontal meridian .

The Golden Law of Glaucomatous Fields: Any lesion that damages nerve fiber bundles at the level of the optic nerve head or arcuate pathways produces a visual field defect that strictly respects the horizontal meridian in the nasal visual field .

2. Lamina Cribrosa Vulnerability & the ISNT Rule

Lamina Cribrosa Cytoarchitecture: The scleral lamina cribrosa provides structural support to axons exiting the globe. The superior and inferior poles of the lamina contain larger laminar pores with thinner, less supportive connective tissue septa compared to the nasal and temporal zones.

Biomechanics of Cupping: Elevated intraocular pressure (IOP) and mechanical strain induce preferential compression, axonal transport arrest, and capillary ischemia at these vulnerable inferior and superior poles .

The ISNT Rule: In a healthy optic disc, neuroretinal rim width follows the hierarchy: I nferior ≥ \ge ≥ S uperior ≥ \ge ≥ N asal ≥ \ge ≥ T emporal. Glaucomatous damage preferentially erodes the inferior rim first , followed by the superior rim , corresponding directly to the appearance of superior and inferior visual field arcuate defects.

Morphological Progression of Glaucomatous Visual Field Defects

Glaucomatous nerve fiber bundle loss follows a characteristic evolutionary pattern across the 24° to 30° visual field: Sequential Evolution of Glaucomatous Field Loss:

  • [1. Isolated Nasal Step / Paracentral Scotoma]
  • │
  • ▼
  • [2. Seidel Scotoma (Sickle-shaped elongation of blind spot)]
  • │
  • ▼
  • [3. Bjerrum / Arcuate Scotoma (Extending 10-20° across raphe)]
  • │
  • ▼
  • [4. Double Arcuate / Ring Scotoma (Superior & Inferior)]
  • │
  • ▼
  • [5. End-Stage Residual Island (Macular Sparing + Temporal Island)]
  • 1. The Nasal Step (Ronchese Nasal Step)

Morphology: A step-like shelf of threshold depression that abuts the horizontal meridian in the nasal field (usually 15° to 30° from fixation).

Mechanism: Asymmetric axon loss between the superior and inferior arcuate bundles creates a sharp step where the two halves of the retina meet at the horizontal raphe.

Significance: Often the earliest detectable visual field defect in open-angle glaucoma, frequently detected on 24-2 perimetry before central paracentral scotomas emerge.

2. Paracentral Scotoma

Morphology: Discrete, circumscribed islands of threshold depression located within 10° to 20° of fixation (frequently within 5° to 10° in the superonasal or inferonasal quadrants).

Significance: Represents focal, localized damage to small sub-bundles within the arcuate stream. In normal-tension glaucoma (NTG), paracentral scotomas are notoriously deep, steep-walled, and occur closer to fixation earlier in the disease course compared to high-tension open-angle glaucoma.

3. Seidel Scotoma

Morphology: An arcuate, sickle-shaped expansion of the physiological blind spot that curves toward the nasal horizontal meridian but has not yet reached it.

4. Arcuate (Bjerrum) Scotoma

Morphology: A complete, dense arch-shaped defect originating at the superior or inferior edge of the physiological blind spot, sweeping across the 10° to 20° zone around fixation, and terminating abruptly at the nasal horizontal raphe.

Anatomical Correlation: An inferior optic disc rim notch produces a superior arcuate scotoma ; a superior optic disc notch produces an inferior arcuate scotoma .

5. Double Arcuate (Ring Scotoma)

Morphology: Simultaneous loss of both superior and inferior arcuate bundles. The defects coalesce nasally at the horizontal raphe, completely encircling the central field.

End-Stage Architecture: In advanced terminal disease, the ring scotoma expands inward and outward, leaving only two surviving zones of vision:

A central foveal island (macular sparing): Subserved by the papillomacular bundle, which is relatively resistant to glaucomatous cupping until late stages.

A temporal crescent of vision: Subserved by nasal retinal fibers, which exit through the nasal lamina cribrosa where structural support is highest.

Retinal Vascular Pathology vs. Glaucomatous Defect Mimics

Retinal vascular occlusions cause profound visual field deficits that must be carefully differentiated from glaucomatous neuropathy:

1. Branch Retinal Artery Occlusion (BRAO)

Pathophysiology: Embolic or thrombotic occlusion of a branch of the central retinal artery, causing immediate ischemic infarction of the inner two-thirds of the retina (ganglion cell and nerve fiber layers).

Perimetric Pattern: A dense, absolute altitudinal or wedge-shaped sectoral defect that sharply respects the horizontal raphe. It perfectly mimics an advanced glaucomatous arcuate or hemifield defect.

Differential Markers:

Onset: Sudden, catastrophic, painless loss of vision (unlike the indolent, slowly progressive course of glaucoma).

Fundus Biomicroscopy: Acute ground-glass retinal whitening, ischemic edema, and arteriolar boxcarring along the distribution of the occluded vessel, often with a visible Hollenhorst (cholesterol) plaque.

Depth of Defect: Deeply absolute (0 dB across the entire territory on automated perimetry), whereas glaucomatous defects typically begin as relative scotomas with sloping borders.

2. Branch Retinal Vein Occlusion (BRVO)

Pathophysiology: Venous compression at an arteriovenous crossing site resulting in downstream thrombosis, massive intraretinal flame hemorrhages, cotton-wool spots, and macular edema.

Perimetric Pattern: Sectoral or quadrant visual field depression corresponding to the drainage territory of the occluded tributary.

Differential Markers: Does not strictly conform to nerve fiber bundle architecture; visual field depression is typically relative and correlates directly with the density of intraretinal hemorrhage, capillary non-perfusion, and overlying cystoid macular edema.

3. Central Retinal Artery Occlusion (CRAO)

Perimetric Pattern: Total amaurosis or a collapsed field with only a faint peripheral temporal island remaining. If a cilioretinal artery (derived from the posterior ciliary circulation) is present (found in ~15–20% of the population), a pristine 5° to 10° central island of 20/20 vision is preserved within a completely blind peripheral field.

Chorioretinal Pathology, Dystrophies & Toxic Retinopathies

Pathologic Entity Primary Visual Field Defect Pattern Ophthalmoscopic / Diagnostic Biomarkers Clinical Distinctions from Glaucoma

Toxoplasmosis (Jensen's Choroiditis) Focal absolute scotoma + overlying arcuate nerve fiber bundle defect Hyperpigmented chorioretinal scar adjacent to active yellowish 'headlight in fog' lesion Active vitritis; arcuate defect arises because retinochoroiditis abuts disc and severs axons

Retinal Detachment (RRD) Dense relative-to-absolute defect in field quadrant opposite to detachment Corrugated neurosensory retinal elevation, tobacco dust (Shafer sign), retinal break Sloping borders; respects neither horizontal nor vertical raphe ; progresses rapidly

Retinitis Pigmentosa (RP) Mid-peripheral ring scotoma (20°–40°) progressing to central tunnel vision Triad: Bone-spicule pigment deposits, waxy disc pallor, arteriolar attenuation Bilateral symmetry; severe nyctalopia; extinguished scotopic b-wave on full-field ERG

Plaquenil Toxicity (Non-Asian) Parafoveal ring scotoma (2° to 6° from fixation, sparing center) Subtle RPE mottling; OCT shows loss of parafoveal ellipsoid zone ('flying saucer' sign) Requires 10-2 automated perimetry with white stimulus; does not respect raphe

Plaquenil Toxicity (Asian Patients) Pericentral defect pattern (extending beyond 7° to 10° into mid-periphery) Peripheral RPE atrophy; wide-field fundus autofluorescence hypoautofluorescence Mandates 24-2 or 30-2 perimetry in addition to 10-2 to detect pericentral loss

Diagnostic Deep Dive: Hydroxychloroquine (Plaquenil) Surveillance Protocol

Hydroxychloroquine binds avidly to melanin within the retinal pigment epithelium (RPE), leading to secondary photoreceptor outer segment degeneration. Once clinically visible as a bull's eye maculopathy , visual loss is permanent and can progress even after immediate drug cessation ("post-cessation burnout"). AAO Plaquenil Screening Guidelines:

  • ├── High Risk Threshold: Cumulative dose > 5.0 mg/kg/day (real body weight) or duration > 5 years
  • ├── Concomitant Risk: Renal impairment (reduced clearance) or Tamoxifen use (5x toxicity risk)

└── Testing Strategy by Ethnicity:

  • ├── Non-Asian Ancestry: 10-2 Visual Field (White Stimulus) + SD-OCT / FAF
  • └── Asian Ancestry: 24-2 or 30-2 Visual Field + 10-2 Visual Field + Wide-field FAF

Ethnic Phenotypes: In individuals of European descent, toxic damage preferentially localizes in the parafoveal zone (2° to 6° eccentricity from the foveal center). On a 10-2 test, this manifests as a ring of sensitivity depression with complete preservation of foveal sensitivity.

The Asian Retinopathy Distribution: Over 50% of Asian patients exhibit a pericentral pattern of toxicity , where photoreceptor loss occurs in the mid-periphery along the vascular arcades outside the central 8° to 10°. Performing only a 10-2 visual field on an Asian patient will completely miss early toxicity; a 24-2 or 30-2 visual field is mandatory .

Stimulus Color Selection: The American Academy of Ophthalmology (AAO) guidelines specify using a standard white Size III stimulus on the 10-2 grid; red stimuli, while historically popular, generate excessive false positive artifacts and test-retest variability.